Company Registration No. 04021434 (England and Wales)
UNITED HEALTHCARE DEVELOPMENTS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
6 Queen Street
Leeds
West Yorkshire
LS1 2TW
UNITED HEALTHCARE DEVELOPMENTS LIMITED
CONTENTS
Page
Company information
1
Balance sheet
2 - 3
Notes to the financial statements
4 - 12
UNITED HEALTHCARE DEVELOPMENTS LIMITED
COMPANY INFORMATION
- 1 -
Directors
Mr D C C Brown
Mrs K S Brown
Secretary
Mrs K S Brown
Company number
04021434
Registered office
Early Lodge Farm
Barningham
Richmond
North Yorkshire
DL11 7DN
Accountants
TC Group
6 Queen Street
Leeds
West Yorkshire
LS1 2TW
UNITED HEALTHCARE DEVELOPMENTS LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 2 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
99,052
121,096
Investment properties
4
94,627,450
87,539,984
Investments
5
200
200
94,726,702
87,661,280
Current assets
Debtors
7
2,396,900
2,215,610
Cash at bank and in hand
3,550,009
5,126,394
5,946,909
7,342,004
Creditors: amounts falling due within one year
8
(3,529,561)
(4,509,473)
Net current assets
2,417,348
2,832,531
Total assets less current liabilities
97,144,050
90,493,811
Creditors: amounts falling due after more than one year
9
(44,629,174)
(43,763,308)
Provisions for liabilities
(11,040,483)
(9,444,760)
Net assets
41,474,393
37,285,743
Capital and reserves
Called up share capital
2
2
Profit and loss reserves
41,474,391
37,285,741
Total equity
41,474,393
37,285,743
UNITED HEALTHCARE DEVELOPMENTS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 3 -
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 31 October 2025 and are signed on its behalf by:
Mr D C C Brown
Director
Company Registration No. 04021434
UNITED HEALTHCARE DEVELOPMENTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
1
Accounting policies
Company information
United Healthcare Developments Limited is a private company limited by shares incorporated in England and Wales. The registered office is Early Lodge Farm, Barningham, Richmond, North Yorkshire, DL11 7DN.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.
1.2
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.
1.3
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and equipment
Straight line over 10-15 years
Fixtures, fittings and equipment
25% Straight line
Motor vehicles
25% Reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
UNITED HEALTHCARE DEVELOPMENTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 5 -
1.4
Investment properties
Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.
1.5
Fixed asset investments
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.
Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.
1.6
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
UNITED HEALTHCARE DEVELOPMENTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 6 -
1.7
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.8
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.9
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
UNITED HEALTHCARE DEVELOPMENTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 7 -
1.10
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.11
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.12
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.13
Leases
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
UNITED HEALTHCARE DEVELOPMENTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
6
6
3
Tangible fixed assets
Plant and equipment
Fixtures, fittings and equipment
Motor vehicles
Total
£
£
£
£
Cost
At 1 April 2024
537,938
33,249
112,862
684,049
Additions
5,726
5,726
At 31 March 2025
537,938
38,975
112,862
689,775
Depreciation and impairment
At 1 April 2024
494,691
24,718
43,544
562,953
Depreciation charged in the year
5,746
4,694
17,330
27,770
At 31 March 2025
500,437
29,412
60,874
590,723
Carrying amount
At 31 March 2025
37,501
9,563
51,988
99,052
At 31 March 2024
43,247
8,531
69,318
121,096
4
Investment property
2025
£
Fair value
At 1 April 2024
87,539,984
Additions
4,172,490
Disposals
(995,779)
Revaluations
3,910,755
At 31 March 2025
94,627,450
UNITED HEALTHCARE DEVELOPMENTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
4
Investment property
(Continued)
- 9 -
The fair value of the investment property has been arrived at on the basis of a valuation carried out at the balance sheet date by the directors who are internal to the company. The valuation was made on an open market value basis by reference to market evidence of transaction prices for similar properties.
All investment properties are held for use in operating leases.
If investment properties were stated on an historical cost basis rather than a fair value basis, the amounts would have been £55,299,225 (2024 - £52,122,513).
5
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
200
200
6
Subsidiaries
Details of the company's subsidiaries at 31 March 2025 are as follows:
Name of undertaking
Registered office
Nature of business
Class of
% Held
shares held
Direct
UHD Commercial Finance Limited
England & Wales
Dormant
Ordinary
100.00
UHD Property Limited
England & Wales
Dormant
Ordinary
100.00
7
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
201,480
56,179
Other debtors
53,565
208,588
Prepayments and accrued income
110,871
127,114
365,916
391,881
UNITED HEALTHCARE DEVELOPMENTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
7
Debtors
(Continued)
- 10 -
2025
2024
Amounts falling due after more than one year:
£
£
Other debtors
955,594
958,072
Deferred tax asset (note 10)
1,075,390
865,657
2,030,984
1,823,729
Total debtors
2,396,900
2,215,610
8
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
1,216,871
1,238,093
Trade creditors
38,772
43,688
Amounts owed to group undertakings
6,881
6,881
Taxation and social security
216,220
3,262
Other creditors
191,223
127,526
Accruals and deferred income
1,859,594
3,090,023
3,529,561
4,509,473
The bank loans are secured via fixed charges on the properties to which they relate.
9
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
35,707,314
34,949,185
Other creditors
8,921,860
8,814,123
44,629,174
43,763,308
The bank loans are secured via fixed charges on the properties to which they relate.
UNITED HEALTHCARE DEVELOPMENTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
9
Creditors: amounts falling due after more than one year
(Continued)
- 11 -
Creditors which fall due after five years are as follows:
2025
2024
£
£
Payable by instalments
11,924,313
5,666,520
Payable other than by instalments
23,783,001
29,282,665
35,707,314
34,949,185
10
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:
Liabilities
Liabilities
Assets
Assets
2025
2024
2025
2024
Balances:
£
£
£
£
Accelerated capital allowances
3,381,911
2,700,095
-
-
Tax losses
-
-
1,075,390
865,657
Revaluations
7,658,572
6,744,665
-
-
11,040,483
9,444,760
1,075,390
865,657
2025
Movements in the year:
£
Liability at 1 April 2024
8,579,103
Charge to profit or loss
1,385,990
Liability at 31 March 2025
9,965,093
11
Operating lease commitments
Lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2025
2024
£
£
Total commitments
417,683
517,740
UNITED HEALTHCARE DEVELOPMENTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 12 -
12
Capital commitments
Amounts contracted for but not provided in the financial statements:
2025
2024
£
£
Acquisition of tangible fixed assets
-
4,163,014
13
Related party transactions
Transactions with related parties
Included within other creditors due within one year is an amount of £159,929 payable to the directors (2024 - £100,854). The loan is interest free and repayable on demand.
14
Parent company
The parent company is United Healthcare Holdings Limited, a company incorporated in England and Wales. The registered office address is Early Lodge, Barningham, Richmond, North Yorkshire, DL11 7DN. The ultimate controlling parties are Mr D C C Brown and Mrs K S Brown, the directors, by virtue of their shareholdings in the United Healthcare Holdings Limited.
2025-03-312024-04-01falsefalsefalse31 October 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityMr D C C BrownMrs Katherine S BrownMrs K S Brown040214342024-04-012025-03-3104021434bus:Director12024-04-012025-03-3104021434bus:CompanySecretaryDirector12024-04-012025-03-3104021434bus:CompanySecretary12024-04-012025-03-3104021434bus:Director22024-04-012025-03-3104021434bus:RegisteredOffice2024-04-012025-03-31040214342025-03-31040214342024-03-3104021434core:PlantMachinery2025-03-3104021434core:FurnitureFittings2025-03-3104021434core:MotorVehicles2025-03-3104021434core:PlantMachinery2024-03-3104021434core:FurnitureFittings2024-03-3104021434core:MotorVehicles2024-03-3104021434core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3104021434core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3104021434core:Non-currentFinancialInstrumentscore:AfterOneYear2025-03-3104021434core:Non-currentFinancialInstrumentscore:AfterOneYear2024-03-3104021434core:CurrentFinancialInstruments2025-03-3104021434core:CurrentFinancialInstruments2024-03-3104021434core:Non-currentFinancialInstruments2025-03-3104021434core:Non-currentFinancialInstruments2024-03-3104021434core:Non-currentFinancialInstrumentscore:MoreThanFiveYears2025-03-3104021434core:Non-currentFinancialInstrumentscore:MoreThanFiveYears2024-03-3104021434core:ShareCapital2025-03-3104021434core:ShareCapital2024-03-3104021434core:RetainedEarningsAccumulatedLosses2025-03-3104021434core:RetainedEarningsAccumulatedLosses2024-03-3104021434core:PlantMachinery2024-04-012025-03-3104021434core:FurnitureFittings2024-04-012025-03-3104021434core:MotorVehicles2024-04-012025-03-31040214342023-04-012024-03-3104021434core:PlantMachinery2024-03-3104021434core:FurnitureFittings2024-03-3104021434core:MotorVehicles2024-03-31040214342024-03-3104021434core:Subsidiary12024-04-012025-03-3104021434core:Subsidiary22024-04-012025-03-3104021434core:Subsidiary112024-04-012025-03-3104021434core:Subsidiary222024-04-012025-03-3104021434bus:PrivateLimitedCompanyLtd2024-04-012025-03-3104021434bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3104021434bus:FRS1022024-04-012025-03-3104021434bus:AuditExemptWithAccountantsReport2024-04-012025-03-3104021434bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP